Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM).
Ann Oncol. 2022 Jun;33(6):602-615. doi: 10.1016/j.annonc.2022.02.225. Epub 2022 Mar 6.
Ann Oncol. 2022.
PMID: 35263633
Free article.
Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors.
Wagener-Ryczek S, Heydt C, Süptitz J, Michels S, Falk M, Alidousty C, Fassunke J, Ihle MA, Tiemann M, Heukamp L, Wolf J, Büttner R, Merkelbach-Bruse S.
Wagener-Ryczek S, et al. Among authors: suptitz j.
BMC Cancer. 2020 May 12;20(1):408. doi: 10.1186/s12885-020-06920-3.
BMC Cancer. 2020.
PMID: 32397977
Free PMC article.
Item in Clipboard
Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1-High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer.
Bischoff P, Reck M, Overbeck T, Christopoulos P, Rittmeyer A, Lüders H, Kollmeier J, Kulhavy J, Kemper M, Reinmuth N, Röper J, Janning M, Sommer L, Aguinarte L, Koch M, Wiesweg M, Wesseler C, Waller CF, Kauffmann-Guerrero D, Stenzinger A, Stephan-Falkenau S, Trautmann M, Lassmann S, Tiemann M, Klauschen F, Sebastian M, Griesinger F, Wolf J, Loges S, Frost N; National Network Genomic Medicine Lung Cancer (nNGM) Collaborator Group.
Bischoff P, et al.
J Thorac Oncol. 2023 Dec 13:S1556-0864(23)02423-1. doi: 10.1016/j.jtho.2023.12.015. Online ahead of print.
J Thorac Oncol. 2023.
PMID: 38096950
Free article.
Item in Clipboard
Cite
Cite